side effects from glp-1 medications Adverse of class drugs. Gastrointestinal issues are GLP-1 medications, commonly used for

According to the SURMOUNT-5 trial published in May 2025, participants on the maximum tolerated dose of Semaglutide (1.7 mg or 2.4 mg) achieved an average weight loss of 13.7% over 72 weeks

In addition, it can boost skin vascular growth and enhance the skins antioxidant capacity, further improving skin resilience and anti-aging performance

The ECS comprises the cannabinoid receptors (CBRs), their endogenous ligands (endocannabinoids) and the enzymes/proteins involved their biosynthesis, degradation, and re-uptake

238 , 239 , 240 According to the Centers for Disease Control and Prevention (CDC), in 2020, people age 75 and older had the highest numbers and rates of TBIrelated hospitalizations and deaths, accounting for about 32% of TBIrelated hospitalizations and 28% of TBIrelated deaths